Publications per year
Publications per year
Personal profile
Fingerprint
Dive into the research topics where Klaus Schmetterer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Publications
- 2 Article
-
Primulagenin A is a potent inverse agonist of the nuclear receptor RAR-related orphan receptor gamma (RORγ)
Schwarz, P. F., Perhal, A. F., Preglej, T., Breit, L., Schmetterer, K. G., Grienke, U., Janneschütz, J., Chen, Y., Rochel, N., Kirchmair, J., Schützenmeister, N., Rollinger, J. M., Bonelli, M. & Dirsch, V. M., Jun 2026, In: Acta pharmaceutica Sinica B. 16, 6, p. 3746-3763 18 p.Publications: Contribution to journal › Article › Peer Reviewed
-
Antiproliferative and Pro-apoptotic Activities of a Novel Resveratrol Prodrug Against Jurkat CD4+ T-Cells
Goldhahn, K., Handler, N., Loebsch, S., Schmetterer, K., Steiner, G., Kloesch, B. & Erker, T., Feb 2016, In: Anticancer Research: International journal of cancer research and treatment. 36, 2, p. 683-689 7 p.Publications: Contribution to journal › Article › Peer Reviewed